Weiyi Peng

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 24 papers. Top paper: “Development of a RIPK1 degrader to enhance antitumor immunity”.

Development of a RIPK1 degrader to enhance antitumor immunity

Nature Communications(2024)10.1038/s41467-024-55006-2

N/A

0.643DataRank · unranked

26 citations

Dong Lu, Xiaoli Qi, Rishi R. Paudel, Hanfeng Lin, Bryan L. Holloman +8 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

The Journal of Experimental Medicine(2022)10.1084/jem.20221333

N/A

0.626DataRank · unranked

64 citations

Yusra B. Medik, Bhakti Patel, Daniel Zamler, Sijie Chen, Thomas Chapman +39 more

IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer

Cell(2024)10.1016/j.cell.2024.09.032

N/A

0.621DataRank · unranked

62 citations

Fanglue Peng, Qin Luo, Yao Ding, Fei Yuan, Liting Zheng +43 more

Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001819

N/A

0.581DataRank · unranked

47 citations

Yunfei Wang, Leilei Shi, Yuan Chen, Chunyu Xu, Arash Saeedi +16 more

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2661

N/A

0.542DataRank · unranked

36 citations

Ashley V. Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li +47 more

Integrated multi-omics analyses identify key anti-viral host factors and pathways controlling SARS-CoV-2 infection

Research Square(2022)10.21203/rs.3.rs-1910932/v1

N/A

0.538DataRank · unranked

11 citations

Yanjun Wei, Jing Zou, Roshni Jaffery, Shaoheng Liang, Caishang Zheng +6 more

PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101326

N/A

0.510DataRank · unranked

29 citations

Lacey E. Dobrolecki, Christina Sallas, Xudong Zhang, Travis Kerr, Deepa Bisht +19 more

MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009600

N/A

0.449DataRank · unranked

19 citations

Jiakai Hou, Roshni Jaffery, Ashley Guerrero, Rongjie Fu, Leilei Shi +18 more

Lymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission

Advanced Science(2024)10.1002/advs.202303775

N/A

0.396DataRank · unranked

13 citations

Ramhari Kumbhar, Hu Wang, Xiuli Yang, Kundlik Gadhave, Cyrus Rastegar +25 more

IL-12-producing cytokine factories induce precursor exhausted T cells and elimination of primary and metastatic tumors

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010685

N/A

0.360DataRank · unranked

10 citations

Jonathon DeBonis, Danna Murungi, Bertha Castillo, Boram Kim, Fangheng Hu +16 more

Peripheral MC1R activation modulates immune responses and is neuroprotective in a mouse model of Parkinson's disease

Research Square(2023)10.21203/rs.3.rs-3042571/v1

N/A

0DataRank · unranked

1 citations

Shuhei Nishiyama, Sonia Lin, Akriti Srivast, Chien‐Wen Su, Weiyi Peng +5 more

Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection

Nature Communications(2024)10.1038/s41467-023-44175-1

N/A

0DataRank · unranked

39 citations

Yanjun Wei, Jing Zou, Roshni Jaffery, Long Sun, Shaoheng Liang +16 more

PPP2R1A mutations portend improved survival after cancer immunotherapy

Nature(2025)10.1038/s41586-025-09203-8

N/A

0DataRank · unranked

29 citations

Anne Knisely, Mitsutake Yano, Minghao Dang, Emily Hinchcliff, Sanghoon Lee +36 more

Soluble immune factor profiles in blood and CSF associated with LRRK2 mutations and Parkinson’s disease

npj Parkinson s Disease(2025)10.1038/s41531-025-01215-5

N/A

0DataRank · unranked

1 citations

Yuhang Zhao, Sarfraz Ahmed, Jackson G. Schumacher, Jae Suk Ahn, L Shi +10 more

Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease

Journal of Neuroimmune Pharmacology(2023)10.1007/s11481-023-10094-7

N/A

0DataRank · unranked

10 citations

Shuhei Nishiyama, Fang Zhou, Sonia Lin, Akriti Srivastava, Chien‐Wen Su +6 more

Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102169

N/A

0DataRank · unranked

35 citations

Wanqin Wang, Min Zhou, Qian Huang, Xiaoxia Wen, Jun Zhao +11 more

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02748-9

N/A

0DataRank · unranked

34 citations

Shruti Malu, Jodi A. McKenzie, Soraya Zorro Manrique, Elien M. Doorduijn, Rina M. Mbofung +24 more

Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0614

N/A

0DataRank · unranked

32 citations

Leilei Shi, Shane W. O’Brien, Kimberly N. Smitheman, Yunfei Wang, Jiakai Hou +15 more

Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors

NAR Cancer(2022)10.1093/narcan/zcac038

N/A

0DataRank · unranked

5 citations

Shaoheng Liang, Chunyu Xu, Yanjun Wei, Yunfei Wang, Yukun Tan +12 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

(2022)10.52519/00101

N/A

0DataRank · unranked

3 citations

Yusra B. Medik, Bhakti K. Patel, Daniel B. Zamler, Sijie Chen, T. Chapman +39 more

Engineering non-cytotoxic delivery of proteins by T cells via fusion to NPC2

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.24.509028

N/A

0DataRank · unranked

1 citations

Irfan Bandey, Ankita Leekha, Mohsen Fathi, Ali Rezvan, Melisa J. Montalvo +5 more

The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0430

N/A

0DataRank · unranked

166 citations

Snigdha Pramanik, Leila J. Williams, Hannah R. Hodges, Courtney W. Hudgens, Grant M. Fischer +11 more

Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.01.034

N/A

0DataRank · unranked

4 citations

Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Feng Wang, Diego M. Marzese, Khalida Wani +12 more

A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment

Scientific Reports(2023)10.1038/s41598-023-41690-5

N/A

0DataRank · unranked

3 citations

Lu Huang, Blair Kreh, Xiuxia Liu, Liliya Tyutyunyk‐Massey, Masanori Kawakami +14 more